Nicola Ternette

PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer

Abstract PRMT5 is expressed at high levels in many cancers, where it regulates diverse cellular pathways that contribute to oncogenesis. Here, we have defined a new role for PRMT5 in regulating and coordinating the interplay between the innate and adaptive immune response. This o...